يعرض 1 - 3 نتائج من 3 نتيجة بحث عن '"De Castro, Gilberto"', وقت الاستعلام: 0.89s تنقيح النتائج
  1. 1
    دورية أكاديمية

    مصطلحات موضوعية: ddc:no

    العلاقة: Tan, Daniel Shao-Weng, Soria, Jean-Charles, De Castro, Gilberto, Jr., Wu, Yi Long, Paz-Ares, Luis, Wolf, Juergen, Geater, Sarayut, Orlov, Sergey, Cortinovis, Diego, Yu, Chong-Jen, Hochmair, Maximilian, Cortot, Alexis, Tsai, Chun-Ming, Moro-Sibilot, Denis, Campelo, Rosario Garcia, Branle, Fabrice, Sen, Paramita, Struebbe, Gero, Mcculloch, Tracey and Crino, Lucio (2017). PROs With Ceritinib Versus Chemotherapy in Patients With Previously Untreated ALK-rearranged Nonsquamous NSCLC (ASCEND-4). J. Thorac. Oncol., 12 (1). S. S1176 - 2. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1556-1380

    الإتاحة: https://kups.ub.uni-koelnTest.de/24505/

  2. 2
    دورية أكاديمية

    مصطلحات موضوعية: ddc:no

    العلاقة: De Castro, Gilberto, Jr., Tan, Daniel Shao-Weng, Crino, Lucio, Wu, Yi Long, Paz-Ares, Luis, Wolf, Juergen, Geater, Sarayut, Orlov, Sergey, Cortinovis, Diego, Yu, Chong-Jen, Hochmair, Maximilian, Cortot, Alexis, Tsai, Chun-Ming, Moro-Sibilot, Denis, Campelo, Rosario Garcia, Branle, Fabrice, Sen, Paramita, Mcculloch, Tracey and Soria, Jean-Charles (2017). First-line Ceritinib Versus Chemotherapy in Patients with ALK-rearranged (ALK plus ) NSCLC: A Randomized, Phase 3 Study (ASCEND-4). J. Thorac. Oncol., 12 (1). S. S7 - 1. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1556-1380

    الإتاحة: https://kups.ub.uni-koelnTest.de/24496/

  3. 3
    دورية أكاديمية

    مصطلحات موضوعية: ddc:no

    العلاقة: Soria, Jean-Charles, Tan, Daniel S. W., Chiari, Rita, Wu, Yi-Long orcid:0000-0002-3611-0258 , Paz-Ares, Luis, Wolf, Juergen, Geater, Sarayut L., Orlov, Sergey orcid:0000-0001-6080-8042 , Cortinovis, Diego, Yu, Chong-Jen orcid:0000-0001-5664-9392 , Hochmair, Maximillian, Cortot, Alexis B., Tsai, Chun-Ming, Moro-Sibilot, Denis, Campelo, Rosario G., McCulloch, Tracey, Sen, Paramita, Dugan, Margaret, Pantano, Serafino, Branle, Fabrice, Massacesi, Cristian and de Castro, Gilberto, Jr. (2017). First-line ceritinib versus platinum-based chemotherapy in advanced ALK-rearranged non-small-cell lung cancer (ASCEND-4): a randomised, open-label, phase 3 study. Lancet, 389 (10072). S. 917 - 930. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1474-547X

    الإتاحة: https://kups.ub.uni-koelnTest.de/23679/